Racial Inequities in Receiving Neoadjuvant Treatment in Patients With Pancreatic Cancer Are Associated With Worse Outcomes in Louisiana
Black patients with PDAC were less likely to receive NAT before resection in Louisiana. Overall survival improved in patients who underwent NAT. These differences were independent of insurance status and poverty zip codes, and future investigations should identify modifiable barriers to access and receipt of NAT in patients with PDAC.
Authors
- James C. Watson (ORCID: https://orcid.org/0000-0002-1164-8588)
- Mary A. Maluccio
- Valentine Nfonsam (ORCID: https://orcid.org/0000-0002-1213-8053)
- Mitch Hargis (ORCID: https://orcid.org/0000-0001-8112-052X)
- Omeed Moaven (ORCID: https://orcid.org/0000-0002-0560-0457)
- Andrew G. Chapple (ORCID: https://orcid.org/0000-0001-5332-2730)
- John Lyons (ORCID: https://orcid.org/0000-0003-0340-1312)
- Mohammad Al Efishat (ORCID: https://orcid.org/0000-0002-2174-5007)
- Xiao‐Cheng Wu (ORCID: https://orcid.org/0000-0003-3663-5027)
- Hannah R. Malinosky (ORCID: https://orcid.org/0009-0000-9392-8366)
Institutions
- Louisiana State University (US)
- Louisiana Cancer Research Center (US)
- Louisiana State University Health Sciences Center New Orleans (US)
Publication Details
- Journal
- Journal of Surgical Oncology
- Published
- 2024-10-13
- DOI
- https://doi.org/10.1002/jso.27901
- Citations
- 1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.28